This inventor holds 3 USPTO granted patents. Top assignee: Columbia University. Active years: 1996-1999.
Company Filing History:
Years Active: 1996-1999
Title: Thomas C Wright, Jr: Innovator in Papillomavirus Detection
Introduction
Thomas C Wright, Jr. is a notable inventor based in Irvington, NY (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of high-risk human papillomavirus (HPV) types. With a total of 3 patents, his work has the potential to impact cervical cancer screening and prevention.
Latest Patents
One of his latest patents focuses on the detection of high oncogenic-risk papillomavirus in high-grade cervical specimens. This invention outlines a method that involves obtaining cervical cell specimens, recovering nucleic acid molecules, and using specific oligonucleotide primers to detect various high-risk HPV types. The process includes amplifying the nucleic acids and detecting complexes indicative of the presence of high-risk HPV.
Another significant patent by Wright is a polymerase chain reaction/restriction fragment polymorphism method for typing human papillomavirus. This method involves obtaining DNA samples from infected patients, amplifying specific portions of the HPV DNA, and analyzing the resulting fragments to determine the type of HPV present.
Career Highlights
Thomas C Wright, Jr. is affiliated with Columbia University, where he continues to advance research in the field of virology and diagnostics. His work is instrumental in developing innovative methods for detecting and typing HPV, which is crucial for effective patient management and treatment.
Collaborations
Wright has collaborated with esteemed colleagues such as Saul J Silverstein and Octavian Lungu. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in HPV detection.
Conclusion
Thomas C Wright, Jr. stands out as a key figure in the field of medical diagnostics, particularly in the detection of high-risk HPV types. His innovative patents and collaborations contribute significantly to advancements in cervical cancer prevention and patient care.